Cat. No. 5131
Chemical Name: N-[(2-Chlorophenyl)methyl]-1-(2,5-d
Biological ActivityProtects against α-synuclein toxicity. Reverses the α-synuclein-induced pathological phenotype in Parkinson's disease cortical neurons. Promotes E3 ubiquitin ligase Rsp5/Nedd4-dependent endosomal transport.
Licensing InformationSold under license from Whitehead Institute for Biomedical Research.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Chung et al (2013) Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons. Science 342 983. PMID: 24158904.
Tardiff et al (2013) Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons. Science 342 979. PMID: 24158909.
If you know of a relevant reference for NAB 2 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses NAB 2 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: NAB 2, supplier, NAB2, α, alpha-synuclein, a-synuclein, toxicity, Parkinsons, disease, parkinson's, NEDD4, rsp5, Tocris Bioscience, Ubiquitin E3 Ligase products
Find multiple products by catalog number
New Products in this Area
Cereblon ubiquitination inhibitor; also TNFα inhibitor and antiangiogenicLenalidomide
Cereblon binder; induces ubiquitination and degradation of CK1α by E3 ubiquitin ligasecis VH 298
Negative control for VH 298VH 298
High-affinity inhibitor of VHLcis MZ 1
Negative Control for MZ1MZ 1
(+)-JQ1 based PROTAC that selectively degrades BRD4 in cells.
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.